Clinical Trials Browser

Prostatic Neoplasms, Castration-Resistant × enzalutamide × 30 days × Clear all

NCT05997615 2026-04-20

AMX-500

Phase 1 Recruiting

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT06863272 2026-04-20

IDeate-Prostate02

Phase 1/2 Recruiting

Neoplasm Metastasis, Prostatic Neoplasms, Castration-Resistant